{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:25:05Z","timestamp":1790015105485,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.atherosclerosis.2006.11.017","type":"journal-article","created":{"date-parts":[[2006,12,19]],"date-time":"2006-12-19T09:32:05Z","timestamp":1166520725000},"page":"398-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: The Korean atherosclerosis study (KAS)"],"prefix":"10.1016","volume":"196","author":[{"given":"Soo","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Kyeong","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Wook","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Funahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib1","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"A novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib3","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","article-title":"AdipoQ is a novel adipose-specific gene dysregulated in obesity","volume":"271","author":"Hu","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(02)09335-2","article-title":"Adiponectin and development of type 2 diabetes in the Pima Indian population","volume":"360","author":"Lindsay","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib6","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib7","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2337\/diacare.26.7.2015","article-title":"Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study","volume":"26","author":"Daimon","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(03)12255-6","article-title":"Adiponectin and protection against type 2 diabetes mellitus","volume":"361","author":"Spranger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib9","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2337\/diacare.25.9.1665","article-title":"Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes","volume":"25","author":"Imagawa","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.ATV.0000048856.22331.50","article-title":"Association of hypoadiponectinemia with coronary artery disease in men","volume":"23","author":"Kumada","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V131134","article-title":"Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib12","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","article-title":"Plasma adiponectin levels and risk of myocardial infarction in men","volume":"291","author":"Pischon","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.54.2.534","article-title":"Adiponectin and future coronary heart disease events among men with type 2 diabetes","volume":"54","author":"Schulze","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib14","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2337\/diabetes.53.7.1671","article-title":"Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting","volume":"53","author":"Rajala","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib15","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1074\/jbc.C100028200","article-title":"A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation","volume":"276","author":"Kim","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1172\/JCI16521","article-title":"Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production","volume":"111","author":"Rajala","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib17","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1126\/science.1092341","article-title":"Regulation of fasted blood glucose by resistin","volume":"303","author":"Banerjee","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","article-title":"Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators","volume":"300","author":"Patel","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib19","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1210\/jc.2002-021808","article-title":"Serum resistin (FIZZ3) protein is increased in obese humans","volume":"88","author":"Degawa-Yamauchi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2337\/diabetes.53.5.1279","article-title":"High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians","volume":"53","author":"Vozarova de Court","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib21","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1210\/jc.2003-030898","article-title":"Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes","volume":"88","author":"McTernan","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.metabol.2003.11.014","article-title":"Resistin serum levels in type 1 diabetes pre- and post-islet transplantation","volume":"53","author":"Shalev","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.0000084503.91330.49","article-title":"Resistin promotes endothelial cell activation: further evidence of adipokine\u2013endothelial interaction","volume":"108","author":"Verma","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib24","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1161\/01.CIR.0000147825.97879.E7","article-title":"Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1\/2 and phosphatidylinositol 3-kinase pathways","volume":"110","author":"Calabro","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib25","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","article-title":"Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects","volume":"88","author":"Lee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib26","first-page":"571","article-title":"Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance","volume":"49","author":"Pfutzner","year":"2003","journal-title":"Clin Lab"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1055\/s-2002-38241","article-title":"Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls","volume":"34","author":"Fehmann","year":"2002","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ahj.2005.04.018","article-title":"Long-term prognostic value of the preoperative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease","volume":"151","author":"Jeger","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000099786.99623.EF","article-title":"Adiponectin and metabolic syndrome","volume":"24","author":"Matsuzawa","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2004.01426.x","article-title":"Adiponectin\u2014journey from an adipocyte secretory protein to biomarker of the metabolic syndrome","volume":"257","author":"Trujillo","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib33","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.2337\/diabetes.53.9.2473","article-title":"Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study","volume":"53","author":"Duncan","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib34","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1161\/01.CIR.0000127953.98131.ED","article-title":"Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages","volume":"109","author":"Kumada","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib35","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/01.CIR.0000042707.50032.19","article-title":"Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"106","author":"Okamoto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib36","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","article-title":"Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway","volume":"102","author":"Ouchi","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib37","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1210\/jc.2003-031916","article-title":"Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes","volume":"89","author":"Looker","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib38","first-page":"507","article-title":"Adiponectin in essential hypertension","volume":"15","author":"Mallamaci","year":"2002","journal-title":"J Nephrol"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cardiores.2005.09.015","article-title":"Resistin is secreted from macrophages in atheromas and promotes atherosclerosis","volume":"69","author":"Jung","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib40","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","article-title":"Resistin is an inflammatory marker of atherosclerosis in humans","volume":"111","author":"Reilly","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/jc.2005-1653","article-title":"Cross-sectional associations of resistin, coronary heart disease, and insulin resistance","volume":"91","author":"Burnett","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2006.11.017_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2003.12.104","article-title":"Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine\u2013endothelial cell interactions","volume":"314","author":"Kawanami","year":"2004","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006006940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006006940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:20:49Z","timestamp":1762186849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915006006940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0021915006006940"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.11.017","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: The Korean atherosclerosis study (KAS)","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}